Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Complement system WP2806,2.0046955175757104e-05,5.560509554140127,60.15044108971156,"['FCGR3A', 'SELPLG', 'RPS19', 'CD93', 'C5AR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.004822472597001218,0,0,12
2,Vitamin D Receptor Pathway WP2877,2.689955258635056e-05,3.9648314127187367,41.72351047270282,"['CEBPA', 'CDKN1A', 'TNFAIP3', 'PRDM1', 'ADRB2', 'HIF1A', 'DUSP10', 'BCL6', 'SPP1', 'PRKCQ', 'CD14', 'MXD1', 'JUNB', 'S100A9', 'S100A8', 'PPARD']",0.004822472597001218,0,0,16
3,"GPCRs, Class A Rhodopsin-like WP455",3.207853168736952e-05,5.819883678662305,60.22021942528299,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH1', 'GPR34', 'HRH2', 'GPR65', 'ADRB2', 'OPRM1']",0.004822472597001218,0,0,11
4,Lung fibrosis WP3624,5.245263878677133e-05,7.130166787527194,70.27207117701428,"['CEBPB', 'SERPINA1', 'FAM13A', 'PDGFB', 'SPP1', 'HMOX1', 'ATP11A', 'IGF1', 'FGF2']",0.005914035023208467,0,0,9
5,Photodynamic therapy-induced unfolded protein response WP3613,7.460356570428867e-05,8.0589929715405,76.58720725330298,"['DNAJC3', 'XBP1', 'HSPA5', 'EDEM1', 'DNAJB11', 'CALR', 'PDIA6', 'HSP90B1']",0.006729241626526839,0,0,8
6,TYROBP causal network in microglia WP3945,9.758716654256639e-05,3.89514687100894,35.97076429415136,"['STAT5A', 'IGSF6', 'LOXL3', 'TCIRG1', 'TNFRSF1B', 'ADAP2', 'BIN2', 'NPC2', 'DPYD', 'ITGAX', 'SPP1', 'HCLS1', 'GAL3ST4', 'C1QC']",0.007335302018449574,0,0,14
7,Nuclear Receptors Meta-Pathway WP2882,0.00020616651491394203,2.386000722927431,20.249573903971363,"['SERPINA1', 'SRC', 'ABCB4', 'PDGFB', 'TNFAIP3', 'SLC2A3', 'SLC5A3', 'DNAJB1', 'SEC14L1', 'FTH1', 'PDE4B', 'HMOX1', 'JUNB', 'PLTP', 'SRGN', 'ABCC3', 'CPT1A', 'HSP90AA1', 'STAT3', 'NRG1', 'SLC7A5', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.013283014032312551,0,0,26
8,Differentiation Pathway WP2848,0.0003408233642171711,9.478417915838902,75.67707446422195,"['NOTCH1', 'WNT5A', 'PDGFB', 'IGF1', 'FGF2', 'VEGFA']",0.01921391715774302,0,0,6
9,Complement and Coagulation Cascades WP558,0.0003847244768543869,7.042692750287687,55.37657424589093,"['C1QB', 'C1QA', 'SERPINA1', 'C5AR1', 'PLAT', 'CD55', 'C1QC']",0.019278971006814277,0,0,7
10,"GPCRs, Other WP117",0.0005656292927795994,6.455063291139241,48.26819829120737,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADRB2', 'GRM1', 'ADGRL2', 'GPR135']",0.025509881104359932,0,0,7
11,Monoamine GPCRs WP58,0.0006296220878382449,22.07313997477932,162.68766733680755,"['CHRM3', 'HRH1', 'HRH2', 'ADRB2']",0.02581450560136804,0,0,4
12,Endochondral Ossification with Skeletal Dysplasias WP4808,0.000907973974964681,4.33563231074818,30.368047029711295,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2', 'VEGFA', 'FGFR1']",0.0314997125160824,0,0,9
13,Endochondral Ossification WP474,0.000907973974964681,4.33563231074818,30.368047029711295,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2', 'VEGFA', 'FGFR1']",0.0314997125160824,0,0,9
14,Complement Activation WP545,0.0013720684747940233,14.71374527112232,96.98470795280927,"['C1QB', 'C1QA', 'CD55', 'C1QC']",0.04420020586657889,0,0,4
15,NRF2 pathway WP2884,0.0017896073823834991,2.886530612244898,18.259497064530247,"['ABCC3', 'HSP90AA1', 'SERPINA1', 'PDGFB', 'SLC2A3', 'NRG1', 'SLC5A3', 'DNAJB1', 'FTH1', 'HMOX1', 'FTL', 'PPARD', 'HSPA1A']",0.05380752863033054,0,0,13
16,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.0019247150270531588,7.888708513708513,49.3279157366123,"['CD63', 'STAT3', 'SPP1', 'HSPB1', 'IGF1']",0.05425290482506091,0,0,5
17,Toll-like Receptor Signaling Pathway WP75,0.002404177020588851,2.774872448979592,16.734000468437188,"['IFNAR2', 'TICAM2', 'LY96', 'RELA', 'IRF7', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR3', 'MAP2K6', 'TLR2']",0.0637814021344454,0,0,13
18,Development and heterogeneity of the ILC family WP3893,0.0025633979753792663,11.03404791929382,65.83378147132962,"['NFIL3', 'IL15', 'ZBTB16', 'RORA']",0.06422736038311384,0,0,4
19,IL-4 signaling pathway WP395,0.002808682870477145,3.2588384782121236,19.145805223207343,"['STAT5A', 'CEBPA', 'CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'FES', 'STAT3', 'JAK3', 'RELA']",0.06572539009365394,0,0,10
20,Cardiac Progenitor Differentiation WP2406,0.0029146514453948533,6.901830808080808,40.29292303653905,"['NOTCH1', 'NRG1', 'ROR2', 'IGF1', 'FGF2']",0.06572539009365394,0,0,5
21,MAPK Signaling Pathway WP382,0.003134573471875262,1.9822337214316517,11.428097081871018,"['DUSP1', 'LRRK2', 'HSPA6', 'PLA2G4C', 'CACNA2D3', 'PDGFB', 'CACNA1B', 'HSPB1', 'CACNA1C', 'FGF2', 'DUSP6', 'RELA', 'CACNB4', 'FGF14', 'DUSP10', 'RASA2', 'MKNK2', 'FGF20', 'MAP3K8', 'CD14', 'HSPA1B', 'HSPA1A', 'MAP2K6', 'FGFR1']",0.06731869694360681,0,0,24
22,Toll-like Receptor Signaling related to MyD88 WP3858,0.0034667050514324434,4.3004219409282705,24.35995806862918,"['TICAM2', 'IRF7', 'TLR5', 'IKBKE', 'RELA', 'TLR3', 'TLR2']",0.07106745355436508,0,0,7
23,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.004408384026777436,4.073617588274484,22.096308351064454,"['HSP90AA1', 'RIPK2', 'CASP1', 'NLRP3', 'PRDM1', 'NLRP1', 'RELA']",0.08284088316985933,0,0,7
24,Oxidative Damage WP3941,0.004408384026777436,4.073617588274484,22.096308351064454,"['C1QB', 'C1QA', 'CDKN1A', 'C5AR1', 'CYCS', 'TNFRSF1B', 'C1QC']",0.08284088316985933,0,0,7
25,PTF1A related regulatory pathway WP4147,0.005092273160830805,16.534005037783377,87.30005840349527,"['NOTCH1', 'PROX1', 'RBPJ']",0.09186460782138771,0,0,3
26,Angiogenesis WP1539,0.005909035522014512,5.52020202020202,28.325661677035825,"['SRC', 'PDGFB', 'HIF1A', 'FGF2', 'VEGFA']",0.09870277853439055,0,0,5
27,White fat cell differentiation WP4149,0.005909035522014512,5.52020202020202,28.325661677035825,"['STAT5A', 'CEBPA', 'CEBPB', 'CEBPD', 'RORA']",0.09870277853439055,0,0,5
28,Iron metabolism in placenta WP2007,0.0067148734393757846,7.354350567465321,36.79698044132472,"['STEAP3', 'TFRC', 'FTH1', 'HAMP']",0.10456090849004544,0,0,4
29,Adipogenesis WP236,0.006835044253994912,2.5096022112726835,12.512104506663656,"['STAT5A', 'CEBPA', 'CDKN1A', 'CEBPB', 'WNT5B', 'CEBPD', 'NAMPT', 'STAT3', 'RORA', 'IGF1', 'HIF1A', 'PPARD']",0.10456090849004544,0,0,12
30,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.006955271074725861,inf,inf,"['FMO4', 'FMO5']",0.10456090849004544,0,0,2
31,Statin inhibition of cholesterol production WP430,0.008013689811624697,5.017791551882461,24.21889264165266,"['LIPC', 'APOC2', 'APOC1', 'APOE', 'PLTP']",0.10952042742553753,0,0,5
32,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.008013689811624697,5.017791551882461,24.21889264165266,"['GSDMD', 'FCGR2A', 'NLRP3', 'IKBKE', 'RELA']",0.10952042742553753,0,0,5
33,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.008013689811624697,5.017791551882461,24.21889264165266,"['P4HA1', 'P3H2', 'TNFRSF11A', 'PLOD1', 'PPIB']",0.10952042742553753,0,0,5
34,Regulatory circuits of the STAT3 signaling pathway WP4538,0.009304591488019376,2.8452139231327047,13.307769117894617,"['PTPRT', 'IFNAR2', 'DEPTOR', 'SRC', 'IL3RA', 'STAT3', 'IL21R', 'JAK3', 'CSF2RA']",0.11970219452452696,0,0,9
35,Macrophage markers WP4146,0.00955494235672499,11.021410579345089,51.25723818647586,"['CD163', 'CD14', 'CD68']",0.11970219452452696,0,0,3
36,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.00955494235672499,11.021410579345089,51.25723818647586,"['LIPC', 'LIPG', 'APOE']",0.11970219452452696,0,0,3
37,IL1 and megakaryocytes in obesity WP2865,0.00986338058796322,6.303008466942893,29.113131642072048,"['NLRP3', 'PLA2G7', 'S100A9', 'TLR2']",0.12022661203165978,0,0,4
38,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.011681001190223007,2.9485424588086184,13.120399426867232,"['CDKN1A', 'HSPA5', 'RIPK2', 'HSPB1', 'NRG1', 'APOE', 'YBX3', 'HSPD1']",0.13863504044185726,0,0,8
39,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.012085606412004197,3.6814159292035398,16.256175896188434,"['IFNAR2', 'OAS1', 'IRF7', 'IKBKE', 'TLR3', 'TLR2']",0.1397591920977921,0,0,6
40,Genes controlling nephrogenesis WP4823,0.013832723779082118,5.514501891551072,23.60602864168707,"['ROBO2', 'CXCL12', 'PDGFB', 'VEGFA']",0.143000839947739,0,0,4
41,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.014807370054507666,3.487257967928671,14.69052838957592,"['TICAM2', 'SRC', 'LY96', 'PLAT', 'CD14', 'TLR3']",0.143000839947739,0,0,6
42,Regulation of toll-like receptor signaling pathway WP1449,0.015066172607387995,2.0690676883780332,8.680366444893158,"['IFNAR2', 'TICAM2', 'LY96', 'TNFAIP3', 'RELA', 'IRF7', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR3', 'MAP2K6', 'TLR2']",0.143000839947739,0,0,14
43,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.015692116893733683,8.265113350125944,34.33821348769155,"['CASP1', 'NLRP3', 'RELA']",0.143000839947739,0,0,3
44,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.015692116893733683,8.265113350125944,34.33821348769155,"['NOTCH1', 'SRC', 'VEGFA']",0.143000839947739,0,0,3
45,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.015692116893733683,8.265113350125944,34.33821348769155,"['APOE', 'RELA', 'TLR2']",0.143000839947739,0,0,3
46,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.015692116893733683,8.265113350125944,34.33821348769155,"['CDKN1A', 'SPP1', 'ENPP1']",0.143000839947739,0,0,3
47,"GPCRs, Class B Secretin-like WP334",0.015692116893733683,8.265113350125944,34.33821348769155,"['ADGRE2', 'CALCR', 'ADGRL2']",0.143000839947739,0,0,3
48,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.015692116893733683,8.265113350125944,34.33821348769155,"['GRM5', 'GRM7', 'GRM1']",0.143000839947739,0,0,3
49,Transcriptional cascade regulating adipogenesis WP4211,0.015692116893733683,8.265113350125944,34.33821348769155,"['CEBPA', 'CEBPB', 'CEBPD']",0.143000839947739,0,0,3
50,Allograft Rejection WP2328,0.015853751657177274,2.76362484157161,11.453426149925697,"['C1QB', 'C1QA', 'CXCL12', 'LRRK2', 'CD55', 'HLA-DPA1', 'VEGFA', 'C1QC']",0.143000839947739,0,0,8
51,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.016911100195646792,1.754137276180141,7.156503046149874,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'ANGPT2', 'PDGFB', 'SLC2A3', 'IGF1', 'HIF1A', 'FGF2', 'VEGFA', 'HSP90B1', 'GNG10', 'FGF14', 'PIK3IP1', 'IL3RA', 'SPP1', 'FGF20', 'ITGAX', 'JAK3', 'FGFR1']",0.14729340094518434,0,0,21
52,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.017189910132296354,2.9744888023369036,12.086635028039371,"['CEBPA', 'CDKN1A', 'CEBPB', 'NOTCH1', 'CEBPD', 'SPP1', 'JUNB']",0.14729340094518434,0,0,7
53,Neovascularisation processes WP4331,0.0173094240578598,3.9411976911976914,15.987484918671747,"['NOTCH1', 'CXCL12', 'PDGFB', 'HIF1A', 'RELA']",0.14729340094518434,0,0,5
54,Oncostatin M Signaling Pathway WP2374,0.018580913350559534,2.4881345177664973,9.916759664779116,"['CEBPB', 'SRC', 'PXN', 'STAT3', 'JAK3', 'JUNB', 'HIF1A', 'RELA', 'VEGFA']",0.15321873278246437,0,0,9
55,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.01868521131493468,4.901218999579656,19.506963889438538,"['CYSLTR1', 'LTC4S', 'ALOX15B', 'PPARD']",0.15321873278246437,0,0,4
56,PI3K-Akt signaling pathway WP4172,0.020616502482644437,1.7148461188599151,6.656455471940577,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'ANGPT2', 'PDGFB', 'IGF1', 'BRCA1', 'FGF2', 'RELA', 'VEGFA', 'HSP90B1', 'GNG10', 'FGF14', 'IL3RA', 'SPP1', 'FGF20', 'PIK3AP1', 'JAK3', 'TLR2', 'FGFR1']",0.16603647535129717,0,0,21
57,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.023569367683685533,6.611335012594458,24.778010215061276,"['ABCC3', 'ABCB4', 'PPARD']",0.18327215216107198,0,0,3
58,Osteoclast Signaling WP12,0.023569367683685533,6.611335012594458,24.778010215061276,"['PDGFB', 'SPP1', 'TNFRSF11A']",0.18327215216107198,0,0,3
59,Glucocorticoid Receptor Pathway WP2880,0.03103790997858367,2.5767088607594935,8.94773983913477,"['SRGN', 'HSP90AA1', 'MGAM', 'SEC14L1', 'PDE4B', 'TNFAIP3', 'CPEB4']",0.23725588814137688,0,0,7
60,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.033198503152341234,5.508816120906801,18.758898794205635,"['STAT3', 'JAK3', 'RELA']",0.23784159249741224,0,0,3
61,NOTCH1 regulation of endothelial cell calcification WP3413,0.033198503152341234,5.508816120906801,18.758898794205635,"['NOTCH1', 'PLAT', 'VEGFA']",0.23784159249741224,0,0,3
62,Peptide GPCRs WP24,0.033198503152341234,5.508816120906801,18.758898794205635,"['CX3CR1', 'C5AR1', 'OPRM1']",0.23784159249741224,0,0,3
63,Spinal Cord Injury WP2431,0.033223991856622996,2.2104060913705585,7.525290000422049,"['C1QB', 'ZFP36', 'SEMA6A', 'FCGR2A', 'TNFSF13', 'PLXNA2', 'LILRB3', 'TNFSF13B', 'RHOB']",0.23784159249741224,0,0,9
64,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.037243821013260146,11.00880503144654,36.22193241831018,"['CDKN1A', 'HIF1A']",0.254499443590611,0,0,2
65,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.037243821013260146,11.00880503144654,36.22193241831018,"['HIF1A', 'VEGFA']",0.254499443590611,0,0,2
66,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.037243821013260146,11.00880503144654,36.22193241831018,"['SRC', 'VEGFA']",0.254499443590611,0,0,2
67,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.03800499395079794,3.063973063973064,10.019307455894898,"['SLC16A1', 'ANGPT2', 'SLC2A3', 'HIF1A', 'VEGFA']",0.25582466077328164,0,0,5
68,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.038952857034190415,3.6746532156368223,11.925731150686811,"['CEBPA', 'PTPN1', 'CEBPB', 'TNFRSF11A']",0.25834909591793936,0,0,4
69,ESC Pluripotency Pathways WP3931,0.04507368342595336,2.0715418781725887,6.420654392659433,"['FGF14', 'WNT5B', 'WNT5A', 'STAT3', 'PDGFB', 'FGF20', 'FGF2', 'MAP2K6', 'FGFR1']",0.29461204674065167,0,0,9
70,Ectoderm Differentiation WP2858,0.04891792034565875,1.8178518453887096,5.48557059830836,"['SDCBP', 'PTPRB', 'PLCXD3', 'ZBTB16', 'PIM1', 'PLXNA2', 'HMGB2', 'SORCS1', 'ROR2', 'LDB2', 'ASTN1', 'PPARD']",0.31517117251274424,0,0,12
71,Cytoplasmic Ribosomal Proteins WP477,0.052736117764684225,1.7930797039077293,5.2760558230360015,"['RPS15A', 'RPL18A', 'RPS19', 'RPS29', 'RPLP1', 'RPL12', 'RPL36A', 'RPL26', 'RPS2', 'RPL39', 'RPS10', 'RPS13']",0.3349857621390505,0,0,12
72,Prolactin Signaling Pathway WP2037,0.05437093608583947,1.9882233502538071,5.789558334969388,"['STAT5A', 'PTPN1', 'SRC', 'PXN', 'STAT3', 'NEK3', 'PPIB', 'CTSD', 'RELA']",0.3405735024265778,0,0,9
73,Notch Signaling Pathway Netpath WP61,0.056865859139125334,2.207341772151899,6.328581594975988,"['CDKN1A', 'NOTCH1', 'SRC', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.3482089427032412,0,0,7
74,GDNF/RET signaling axis WP4830,0.058678225377929785,7.3383647798742135,20.80930244127197,"['ROBO2', 'SALL1']",0.3482089427032412,0,0,2
75,Inflammatory Response Pathway WP453,0.058678225377929785,7.3383647798742135,20.80930244127197,"['IL4R', 'TNFRSF1B']",0.3482089427032412,0,0,2
76,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.058678225377929785,7.3383647798742135,20.80930244127197,"['STAT3', 'CHI3L1']",0.3482089427032412,0,0,2
77,Ferroptosis WP4313,0.0595932200764601,2.363915477695503,6.666746268564191,"['STEAP3', 'TFRC', 'ACSL1', 'FTH1', 'HMOX1', 'FTL']",0.34904600330498053,0,0,6
78,Hematopoietic Stem Cell Differentiation WP2849,0.06052183974797969,2.6253607503607506,7.36348316766089,"['SEC14L2', 'STAT5A', 'NOTCH1', 'PIM1', 'RUNX1']",0.3499403811069082,0,0,5
79,IL-18 signaling pathway WP4754,0.06357473237104286,1.544914469952533,4.257072347593703,"['SPON1', 'CPT1A', 'GRN', 'CEBPB', 'NRN1', 'TICAM2', 'TNFAIP2', 'PLOD3', 'HSPB1', 'TNFAIP3', 'PLA2G7', 'RELA', 'VEGFA', 'GRM7', 'NFKBIZ', 'SPP1', 'HMOX1', 'CYCS']",0.36293929492835864,0,0,18
80,Neural Crest Differentiation WP2064,0.06707843565304486,2.282139587601901,6.166096207490726,"['NOTCH1', 'TCF4', 'RBPJ', 'FGF2', 'FGFR1', 'RHOB']",0.3781546809940404,0,0,6
81,Prion disease pathway WP3995,0.06939753748771949,2.505739210284665,6.685071398934587,"['PDIA3', 'HSPA5', 'STAT3', 'HSP90B1', 'FGFR1']",0.38271309883477383,0,0,5
82,Acute viral myocarditis WP4298,0.07094371797967493,1.9623151668779044,5.1920277317164025,"['SGCB', 'SRC', 'STAT3', 'CASP1', 'CYCS', 'TLR5', 'TLR3', 'CD55']",0.38271309883477383,0,0,8
83,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.07212996319502389,3.6712846347607053,9.652856347663917,"['RAB27A', 'RAB27B', 'MYRIP']",0.38271309883477383,0,0,3
84,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.07212996319502389,3.6712846347607053,9.652856347663917,"['PDGFB', 'IGF1', 'FGF2']",0.38271309883477383,0,0,3
85,Pregnane X receptor pathway WP2876,0.07212996319502389,3.6712846347607053,9.652856347663917,"['ABCC3', 'HSP90AA1', 'SRC']",0.38271309883477383,0,0,3
86,EPO Receptor Signaling WP581,0.07972641007877745,2.7547288776796974,6.967134605206858,"['STAT5A', 'SRC', 'STAT3', 'PDK1']",0.40906932443727395,0,0,4
87,IL17 signaling pathway WP2112,0.07972641007877745,2.7547288776796974,6.967134605206858,"['CEBPB', 'CEBPD', 'STAT3', 'RELA']",0.40906932443727395,0,0,4
88,Farnesoid X receptor pathway WP2879,0.08323989866966926,5.50314465408805,13.680974420985644,"['ABCB4', 'FKBP5']",0.40906932443727395,0,0,2
89,FOXP3 in COVID-19 WP5063,0.08323989866966926,5.50314465408805,13.680974420985644,"['STAT5A', 'STAT3']",0.40906932443727395,0,0,2
90,Codeine and Morphine Metabolism WP1604,0.08344651407589623,inf,inf,['ABCC3'],0.40906932443727395,0,0,1
91,"COVID-19, thrombosis and anticoagulation WP4927",0.08344651407589623,inf,inf,['F13A1'],0.40906932443727395,0,0,1
92,SCFA and skeletal muscle substrate metabolism WP4030,0.08344651407589623,inf,inf,['PPARD'],0.40906932443727395,0,0,1
93,Transcription factor regulation in adipogenesis WP3599,0.08816340313454704,3.303778337531486,8.023434929316602,"['CEBPA', 'CEBPB', 'CEBPD']",0.423315632593203,0,0,3
94,Aryl Hydrocarbon Receptor Netpath WP2586,0.08916848136663921,2.296401515151515,5.55092523734259,"['CDKN1A', 'HSP90AA1', 'SRC', 'RELA', 'VEGFA']",0.423315632593203,0,0,5
95,Hepatitis C and Hepatocellular Carcinoma WP3646,0.08916848136663921,2.296401515151515,5.55092523734259,"['CDKN1A', 'STAT3', 'BRCA1', 'HIF1A', 'VEGFA']",0.423315632593203,0,0,5
96,Aryl Hydrocarbon Receptor Pathway WP2873,0.09227955368262818,2.59238928862844,6.177489160972265,"['SLC7A5', 'HSP90AA1', 'SRC', 'JUNB']",0.4290523578439723,0,0,4
97,The influence of laminopathies on Wnt signaling WP4844,0.09227955368262818,2.59238928862844,6.177489160972265,"['CEBPA', 'CEBPB', 'CEBPD', 'SPP1']",0.4290523578439723,0,0,4
98,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.10219029317253522,2.0045971727387655,4.572322945667081,"['RYR2', 'CACNB4', 'SGCB', 'CACNA2D3', 'CTNNA3', 'CACNA1C']",0.46702758953067997,0,0,6
99,Hepatitis B infection WP4666,0.10251825136039316,1.5442314022383148,3.5173181546265493,"['STAT5A', 'CDKN1A', 'TICAM2', 'SRC', 'STAT3', 'RELA', 'IRF7', 'CYCS', 'IKBKE', 'JAK3', 'TLR3', 'MAP2K6', 'TLR2']",0.46702758953067997,0,0,13
100,IL-9 signaling pathway WP22,0.10553462321605518,3.003091367071216,6.753100200496154,"['STAT5A', 'STAT3', 'JAK3']",0.4730239429453187,0,0,3
101,Aspirin and miRNAs WP4707,0.11025903655162259,4.402012578616352,9.70609791732453,"['PDK1', 'VEGFA']",0.4730239429453187,0,0,2
102,Caloric restriction and aging WP4191,0.11025903655162259,4.402012578616352,9.70609791732453,"['NAMPT', 'IGF1']",0.4730239429453187,0,0,2
103,Differentiation of white and brown adipocyte WP2895,0.11025903655162259,4.402012578616352,9.70609791732453,"['CEBPA', 'CEBPB']",0.4730239429453187,0,0,2
104,Genes targeted by miRNAs in adipocytes WP1992,0.11025903655162259,4.402012578616352,9.70609791732453,"['IGF1', 'KCNJ2']",0.4730239429453187,0,0,2
105,Platelet-mediated interactions with vascular and circulating cells WP4462,0.11025903655162259,4.402012578616352,9.70609791732453,"['SELPLG', 'TLR2']",0.4730239429453187,0,0,2
106,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.11153151976965028,2.119269619269619,4.648507791588084,"['IFITM3', 'BST2', 'IFITM2', 'JUNB', 'MAP2K6']",0.4730239429453187,0,0,5
107,Cytosolic DNA-sensing pathway WP4655,0.11222519267217095,1.945415334275303,4.255105366164071,"['POLR1C', 'CASP1', 'IRF7', 'IKBKE', 'RELA', 'POLR2K']",0.4730239429453187,0,0,6
108,Bladder cancer WP2828,0.11995914014952377,2.318975243910533,4.917628393656075,"['CDKN1A', 'SRC', 'TYMP', 'VEGFA']",0.49535675122763434,0,0,4
109,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.12273985516577751,1.8896153151526096,3.9638236773866193,"['STAT5A', 'ANGPT2', 'SRC', 'PXN', 'STAT3', 'RELA']",0.49535675122763434,0,0,6
110,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.1236324789867329,2.040544332210999,4.265639561661012,"['STAT5A', 'SRC', 'FES', 'STAT3', 'RELA']",0.49535675122763434,0,0,5
111,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.12411377580648043,2.7525188916876573,5.743286424951828,"['HIF1A', 'VEGFA', 'PDK1']",0.49535675122763434,0,0,3
112,Immune response to tuberculosis WP4197,0.12411377580648043,2.7525188916876573,5.743286424951828,"['IFNAR2', 'OAS1', 'PTPN2']",0.49535675122763434,0,0,3
113,Vitamin B12 metabolism WP1533,0.12411377580648043,2.7525188916876573,5.743286424951828,"['PLAT', 'APOE', 'RELA']",0.49535675122763434,0,0,3
114,Type 2 papillary renal cell carcinoma WP4241,0.13498579599071045,2.2027742749054227,4.411244309429803,"['CDKN1A', 'PDGFB', 'HIF1A', 'VEGFA']",0.5198130458198961,0,0,4
115,Androgen receptor signaling pathway WP138,0.13502305529886474,1.601195349598821,3.206089036351982,"['CDKN1A', 'SRC', 'LIMK2', 'STAT3', 'BRCA1', 'CALR', 'FKBP4', 'RELA', 'RHOB']",0.5198130458198961,0,0,9
116,PPAR signaling pathway WP3942,0.13631149213766228,1.96744227994228,3.920743821925212,"['CPT1A', 'ACSL1', 'OLR1', 'PLTP', 'PPARD']",0.5198130458198961,0,0,5
117,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.1391556121304356,3.667924528301887,7.233743061958606,"['STAT3', 'TCF4']",0.5198130458198961,0,0,2
118,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.1391556121304356,3.667924528301887,7.233743061958606,"['STAT3', 'HMOX1']",0.5198130458198961,0,0,2
119,Leptin and adiponectin WP3934,0.1391556121304356,3.667924528301887,7.233743061958606,"['CPT1A', 'LEPR']",0.5198130458198961,0,0,2
120,Apoptosis WP254,0.1393960772769823,1.7148523206751054,3.379006612043344,"['CASP4', 'CASP1', 'IRF7', 'CYCS', 'IGF1', 'TNFRSF1B', 'RELA']",0.5198130458198961,0,0,7
121,Fluoropyrimidine Activity WP1601,0.14376630472246243,2.5404960279015696,4.927460180157348,"['ABCC3', 'DPYD', 'TYMP']",0.5198130458198961,0,0,3
122,SARS coronavirus and innate immunity WP4912,0.14376630472246243,2.5404960279015696,4.927460180157348,"['IFNAR2', 'IKBKE', 'TLR3']",0.5198130458198961,0,0,3
123,Modulators of TCR signaling and T cell activation WP5072,0.15699855201026658,1.739836316454854,3.2213394688370194,"['GNA13', 'RASA2', 'TNFAIP3', 'MAP3K8', 'PRKCQ', 'RELA']",0.5198130458198961,0,0,6
124,Blood Clotting Cascade WP272,0.15993782708834164,10.996231155778894,20.15576314075131,['PLAT'],0.5198130458198961,0,0,1
125,Composition of Lipid Particles WP3601,0.15993782708834164,10.996231155778894,20.15576314075131,['APOE'],0.5198130458198961,0,0,1
126,Drug Induction of Bile Acid Pathway WP2289,0.15993782708834164,10.996231155778894,20.15576314075131,['ABCC3'],0.5198130458198961,0,0,1
127,GABA metabolism (aka GHB) WP4157,0.15993782708834164,10.996231155778894,20.15576314075131,['ADHFE1'],0.5198130458198961,0,0,1
128,Gene regulatory network modelling somitogenesis  WP2854,0.15993782708834164,10.996231155778894,20.15576314075131,['NOTCH1'],0.5198130458198961,0,0,1
129,Hfe effect on hepcidin production WP3924,0.15993782708834164,10.996231155778894,20.15576314075131,['HAMP'],0.5198130458198961,0,0,1
130,Osteoblast Signaling WP322,0.15993782708834164,10.996231155778894,20.15576314075131,['PDGFB'],0.5198130458198961,0,0,1
131,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.15993782708834164,10.996231155778894,20.15576314075131,['VEGFA'],0.5198130458198961,0,0,1
132,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.15993782708834164,10.996231155778894,20.15576314075131,['HRH2'],0.5198130458198961,0,0,1
133,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.15993782708834164,10.996231155778894,20.15576314075131,['NOTCH1'],0.5198130458198961,0,0,1
134,Osteoblast differentiation WP4787,0.16058218151703907,1.641502827901966,3.002225666495213,"['NOTCH1', 'WNT5B', 'WNT5A', 'PRKCQ', 'RBPJ', 'FGF2', 'FGFR1']",0.5198130458198961,0,0,7
135,Breast cancer pathway WP4262,0.16167290983878488,1.5267668879344005,2.7820441793079755,"['CDKN1A', 'NOTCH1', 'WNT5B', 'WNT5A', 'FGF20', 'IGF1', 'BRCA1', 'FGF2', 'FGFR1']",0.5198130458198961,0,0,9
136,NRF2-ARE regulation WP4357,0.16435604536131534,2.3587621446563514,4.259264442379587,"['CEBPB', 'SRC', 'HMOX1']",0.5198130458198961,0,0,3
137,Nuclear receptors WP170,0.16435604536131534,2.3587621446563514,4.259264442379587,"['RORA', 'NR1D2', 'PPARD']",0.5198130458198961,0,0,3
138,Vitamin D in inflammatory diseases WP4482,0.16435604536131534,2.3587621446563514,4.259264442379587,"['DUSP1', 'RELA', 'MAP2K6']",0.5198130458198961,0,0,3
139,Regulation of Actin Cytoskeleton WP51,0.16694032748386653,1.4444747364594692,2.585781455349424,"['GNA13', 'CHRM3', 'FGF14', 'PXN', 'PDGFB', 'FGF20', 'IQGAP1', 'CD14', 'PFN1', 'FGF2', 'FGFR1']",0.5198130458198961,0,0,11
140,Fatty acid beta-oxidation WP143,0.16713108816521718,2.0020635102602315,3.5816452028368637,"['CPT1A', 'LIPC', 'GK', 'ACSL1']",0.5198130458198961,0,0,4
141,3q29 copy number variation syndrome WP4906,0.16925930538060632,1.6950306330837304,3.0109225579551704,"['STAT5A', 'TFRC', 'PXN', 'HIF1A', 'HAMP', 'PIGX']",0.5198130458198961,0,0,6
142,Galanin receptor pathway WP4970,0.16942908588808142,3.1435759209344116,5.580855756679836,"['CDKN1A', 'VEGFA']",0.5198130458198961,0,0,2
143,Leptin Insulin Overlap WP3935,0.16942908588808142,3.1435759209344116,5.580855756679836,"['STAT3', 'LEPR']",0.5198130458198961,0,0,2
144,LTF danger signal response pathway WP4478,0.16942908588808142,3.1435759209344116,5.580855756679836,"['CD14', 'TLR2']",0.5198130458198961,0,0,2
145,Omega-3/Omega-6 FA synthesis WP4723,0.16942908588808142,3.1435759209344116,5.580855756679836,"['ACSL1', 'ELOVL5']",0.5198130458198961,0,0,2
146,Pyrimidine metabolism and related diseases WP4225,0.16942908588808142,3.1435759209344116,5.580855756679836,"['DPYD', 'TYMP']",0.5198130458198961,0,0,2
147,Tryptophan catabolism leading to NAD+ production WP4210,0.16942908588808142,3.1435759209344116,5.580855756679836,"['HAAO', 'NAMPT']",0.5198130458198961,0,0,2
148,VEGFA-VEGFR2 Signaling Pathway WP3888,0.18413105902231255,1.2079323652100202,2.0439514117982585,"['SRC', 'PXN', 'PLOD3', 'HSPB1', 'IQGAP1', 'ADRB2', 'LDB2', 'APOLD1', 'RELA', 'STIP1', 'SDCBP', 'RPL18A', 'DNAJB4', 'IER5', 'TMSB10', 'CLIC1', 'MAP2K6', 'TXNDC5', 'PTPN1', 'HSP90AA1', 'SDF2L1', 'STAT3', 'PTPN14', 'PDIA6', 'VEGFA', 'TXNIP', 'CYCS', 'HYOU1', 'RPL26', 'CALR', 'PFN1', 'HSPA1A']",0.5611020785071822,0,0,32
149,TNF-alpha signaling pathway WP231,0.1932157241004199,1.494275096131125,2.4565105151383806,"['HSP90AA1', 'TNFAIP3', 'MAP3K8', 'PYGL', 'KSR2', 'TNFRSF1B', 'NSMAF', 'MAP2K6']",0.5756183644906412,0,0,8
150,Autosomal recessive Osteopetrosis pathways WP4788,0.20064920469158318,2.750314465408805,4.41754724476957,"['TNFRSF11A', 'TCIRG1']",0.5756183644906412,0,0,2
151,Biomarkers for pyrimidine metabolism disorders WP4584,0.20064920469158318,2.750314465408805,4.41754724476957,"['DPYD', 'TYMP']",0.5756183644906412,0,0,2
152,Development of ureteric collection system WP5053,0.20064920469158318,2.750314465408805,4.41754724476957,"['ROBO2', 'SALL1']",0.5756183644906412,0,0,2
153,Kynurenine Pathway and links to Cellular Senescence WP5044,0.20064920469158318,2.750314465408805,4.41754724476957,"['CDKN1A', 'HAAO']",0.5756183644906412,0,0,2
154,"NAD metabolism, sirtuins and aging WP3630",0.20064920469158318,2.750314465408805,4.41754724476957,"['NAMPT', 'HIF1A']",0.5756183644906412,0,0,2
155,Osteopontin Signaling WP1434,0.20064920469158318,2.750314465408805,4.41754724476957,"['SPP1', 'RELA']",0.5756183644906412,0,0,2
156,Ovarian infertility WP34,0.20064920469158318,2.750314465408805,4.41754724476957,"['CEBPB', 'MSH5']",0.5756183644906412,0,0,2
157,PPAR-alpha pathway WP2878,0.20064920469158318,2.750314465408805,4.41754724476957,"['CPT1A', 'PLTP']",0.5756183644906412,0,0,2
158,NO/cGMP/PKG mediated Neuroprotection WP4008,0.20165787492133327,1.8348045397225725,2.937857297896126,"['TSPO', 'CYCS', 'RELA', 'PPID']",0.5756183644906412,0,0,4
159,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.2078089473687508,2.0634445843828715,3.2419523669355774,"['SCO2', 'NAMPT', 'RELA']",0.5870216811068983,0,0,3
160,AGE/RAGE pathway WP2324,0.2082560287740659,1.5734152067906808,2.468668081617425,"['STAT5A', 'SRC', 'STAT3', 'CYCS', 'HIF1A', 'RELA']",0.5870216811068983,0,0,6
161,Disruption of postsynaptic signaling by CNV WP4875,0.21965617983061916,1.7612105926860024,2.66945240771602,"['RYR2', 'NRXN3', 'DLGAP1', 'GRM1']",0.6130640273798095,0,0,4
162,Dopaminergic Neurogenesis WP2855,0.23005288422014658,5.49748743718593,8.078261282493997,['STAT3'],0.6130640273798095,0,0,1
163,EV release from cardiac cells and their functional effects WP3297,0.23005288422014658,5.49748743718593,8.078261282493997,['CXCL12'],0.6130640273798095,0,0,1
164,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.23005288422014658,5.49748743718593,8.078261282493997,['ELOVL5'],0.6130640273798095,0,0,1
165,Nephrogenesis WP5052,0.23005288422014658,5.49748743718593,8.078261282493997,['FGF20'],0.6130640273798095,0,0,1
166,IL-7 signaling pathway WP205,0.2304117505689146,1.9418432360349682,2.850407123271985,"['STAT5A', 'STAT3', 'JAK3']",0.6130640273798095,0,0,3
167,7-oxo-C and 7beta-HC pathways WP5064,0.23244777978258854,2.4444444444444446,3.5666636677647983,"['NPC2', 'ACOT11']",0.6130640273798095,0,0,2
168,Eicosanoid Synthesis WP167,0.23244777978258854,2.4444444444444446,3.5666636677647983,"['LTC4S', 'ALOX15B']",0.6130640273798095,0,0,2
169,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.23244777978258854,2.4444444444444446,3.5666636677647983,"['IL4R', 'STAT3']",0.6130640273798095,0,0,2
170,Omega-9 FA synthesis WP4724,0.23244777978258854,2.4444444444444446,3.5666636677647983,"['ACSL1', 'ELOVL5']",0.6130640273798095,0,0,2
171,Phytochemical activity on NRF2 transcriptional activation WP3,0.23244777978258854,2.4444444444444446,3.5666636677647983,"['CEBPB', 'HMOX1']",0.6130640273798095,0,0,2
172,Kit receptor signaling pathway WP304,0.23585354956250196,1.5015515457993334,2.16905760543584,"['STAT5A', 'SRC', 'STAT3', 'SOCS6', 'JUNB', 'SH2B2']",0.6181659816372895,0,0,6
173,Fas ligand pathway and stress induction of heat shock proteins WP314,0.23805934817266622,1.6932777184983994,2.4302519108194747,"['RIPK2', 'HSPB1', 'CYCS', 'LMNB1']",0.6181659816372895,0,0,4
174,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.23849419247203632,1.5726911976911977,2.254311791641979,"['DDX3Y', 'CXCL12', 'IRF7', 'IKBKE', 'RELA']",0.6181659816372895,0,0,5
175,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.24451723504296666,1.4275668073136427,2.01068428101544,"['WNT5A', 'STAT3', 'NRG1', 'IGF1', 'FGF2', 'IKBKE', 'MAP2K6']",0.6301558457393026,0,0,7
176,Ebola Virus Pathway on Host WP4217,0.24665863776144747,1.3274444665574623,1.8580903012633343,"['BST2', 'SCIN', 'NPC2', 'RASA2', 'IRF7', 'IQGAP1', 'IKBKE', 'RELA', 'HLA-DPA1', 'RHOB']",0.6320627592637091,0,0,10
177,Unfolded protein response WP4925,0.2534337843861907,1.8337531486146095,2.5171062025991717,"['XBP1', 'HSPA5', 'TXNIP']",0.644588019248752,0,0,3
178,Gastrin signaling pathway WP4659,0.25440502755272254,1.3396899437508574,1.8338046847491802,"['CDKN1A', 'SRC', 'PXN', 'STAT3', 'PRKCQ', 'TCF4', 'RELA', 'RHOB', 'VEGFA']",0.644588019248752,0,0,9
179,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.25680421180909657,1.6303769090654336,2.2164017148175743,"['CDKN1A', 'HSP90AA1', 'JUNB', 'MAP2K6']",0.6448357655575577,0,0,4
180,MECP2 and Associated Rett Syndrome WP3584,0.26448835191091846,1.4359368988072336,1.909735861980817,"['RBFOX1', 'CEBPD', 'BCL6', 'IGF1', 'FGF2', 'FKBP5']",0.6448357655575577,0,0,6
181,Canonical and non-canonical Notch signaling WP3845,0.26451134507349927,2.1997484276729558,2.9253819405913424,"['NOTCH1', 'RBPJ']",0.6448357655575577,0,0,2
182,Imatinib and Chronic Myeloid Leukemia WP3640,0.26451134507349927,2.1997484276729558,2.9253819405913424,"['NOP2', 'PIM1']",0.6448357655575577,0,0,2
183,Kallmann's Syndrome WP5074,0.26451134507349927,2.1997484276729558,2.9253819405913424,"['PRKCQ', 'FGFR1']",0.6448357655575577,0,0,2
184,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.26451134507349927,2.1997484276729558,2.9253819405913424,"['CPT1A', 'ACSL1']",0.6448357655575577,0,0,2
185,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.26451134507349927,2.1997484276729558,2.9253819405913424,"['ZBTB16', 'PPARD']",0.6448357655575577,0,0,2
186,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.2707092799406858,1.3762658227848101,1.798380040344814,"['SRC', 'STAT3', 'PDGFB', 'NRG1', 'IGF1', 'FGF2', 'VEGFA']",0.656397232544351,0,0,7
187,SARS-CoV-2 mitochondrial interactions WP5038,0.27675918583630693,1.7370409651332361,2.231415879625071,"['IRF7', 'IKBKE', 'TLR3']",0.6621541950114959,0,0,3
188,Non-small cell lung cancer WP4255,0.2791277904310985,1.4052236597896548,1.7931856374174422,"['STAT5A', 'CDKN1A', 'STAT3', 'CYCS', 'JAK3', 'PDK1']",0.6621541950114959,0,0,6
189,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.2791277904310985,1.4052236597896548,1.7931856374174422,"['NHSL1', 'NOTCH1', 'SRC', 'PRKCQ', 'MGLL', 'FGFR1']",0.6621541950114959,0,0,6
190,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.2874496515592269,1.448032961190856,1.8052736385314354,"['STAT5A', 'CDKN1A', 'SRC', 'PFN1', 'PFN2']",0.6621541950114959,0,0,5
191,RANKL/RANK signaling pathway WP2018,0.2874496515592269,1.448032961190856,1.8052736385314354,"['CALCR', 'SRC', 'TNFRSF11A', 'RELA', 'MAP2K6']",0.6621541950114959,0,0,5
192,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.2874496515592269,1.448032961190856,1.8052736385314354,"['MKNK2', 'IRF7', 'MAP3K8', 'RELA', 'MAP2K6']",0.6621541950114959,0,0,5
193,miR-509-3p alteration of YAP1/ECM axis WP3967,0.2943225771968378,3.6645728643216082,4.482061791029843,['GPC6'],0.6621541950114959,0,0,1
194,miR-517 relationship with ARCN1 and USP1 WP3596,0.2943225771968378,3.6645728643216082,4.482061791029843,['CDKN1A'],0.6621541950114959,0,0,1
195,Role of Osx and miRNAs in tooth development WP3971,0.2943225771968378,3.6645728643216082,4.482061791029843,['NOTCH1'],0.6621541950114959,0,0,1
196,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2943225771968378,3.6645728643216082,4.482061791029843,['STAT3'],0.6621541950114959,0,0,1
197,Microglia Pathogen Phagocytosis Pathway WP3937,0.29507250178802324,1.5175892507718398,1.8522695579374637,"['C1QB', 'C1QA', 'FCER1G', 'C1QC']",0.6621541950114959,0,0,4
198,Constitutive Androstane Receptor Pathway WP2875,0.2965746061914017,1.999542595769011,2.430356983650078,"['ABCC3', 'HSP90AA1']",0.6621541950114959,0,0,2
199,Ebstein-Barr virus LMP1 signaling WP262,0.2965746061914017,1.999542595769011,2.430356983650078,"['HSP90AA1', 'RELA']",0.6621541950114959,0,0,2
200,Gastric Cancer Network 1 WP2361,0.2965746061914017,1.999542595769011,2.430356983650078,"['NOTCH1', 'ECT2']",0.6621541950114959,0,0,2
201,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.2965746061914017,1.999542595769011,2.430356983650078,"['TLR5', 'TLR2']",0.6621541950114959,0,0,2
202,Wnt signaling in kidney disease WP4150,0.2965746061914017,1.999542595769011,2.430356983650078,"['WNT5B', 'WNT5A']",0.6621541950114959,0,0,2
203,Interleukin-11 Signaling Pathway WP2332,0.3144769950965878,1.4668348045397226,1.6968995605090376,"['SRC', 'FES', 'STAT3', 'RELA']",0.6986555870277829,0,0,4
204,Vitamin D-sensitive calcium signaling in depression WP4698,0.3238925299982274,1.5712486505937389,1.7713369778776924,"['GRM5', 'ATP2B4', 'CACNA1C']",0.6986555870277829,0,0,3
205,Apoptosis Modulation and Signaling WP1772,0.32401156534640096,1.3204551201011379,1.488121319635739,"['CASP4', 'CASP1', 'CYCS', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.6986555870277829,0,0,6
206,Senescence and Autophagy in Cancer WP615,0.3250281168078573,1.2839240506329115,1.4429298106779809,"['CDKN1A', 'CEBPB', 'SRC', 'IRF7', 'PLAT', 'IGF1', 'ATG14']",0.6986555870277829,0,0,7
207,Apoptosis Modulation by HSP70 WP384,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['CYCS', 'HSPA1A']",0.6986555870277829,0,0,2
208,Heart Development WP1591,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['NOTCH1', 'VEGFA']",0.6986555870277829,0,0,2
209,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['PXN', 'PRKCQ']",0.6986555870277829,0,0,2
210,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['ABCC3', 'HMOX1']",0.6986555870277829,0,0,2
211,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['SLC2A3', 'RELA']",0.6986555870277829,0,0,2
212,Triacylglyceride synthesis WP325,0.3284145996671618,1.8327044025157233,2.0406768490413145,"['LIPC', 'GK']",0.6986555870277829,0,0,2
213,G13 Signaling Pathway WP524,0.33398600045898563,1.4193548387096775,1.5565442862517116,"['GNA13', 'IQGAP1', 'IQGAP2', 'PFN1']",0.7071722357136269,0,0,4
214,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.33769789016225066,1.240007854477945,1.3461569899553867,"['RYR2', 'CPT1A', 'CEBPB', 'RORA', 'HIF1A', 'HSP90B1', 'HSPD1', 'VEGFA']",0.7082498100687193,0,0,8
215,Cardiac Hypertrophic Response WP2795,0.3380060125497932,1.3416173934466618,1.4552411104424412,"['NRG1', 'IGF1', 'FGF2', 'IKBKE', 'MAP2K6']",0.7082498100687193,0,0,5
216,Pathways in clear cell renal cell carcinoma WP4018,0.3392061174608501,1.2944151111772142,1.3994534546414528,"['DEPTOR', 'STAT3', 'PDGFB', 'HIF1A', 'KCNJ2', 'VEGFA']",0.7082498100687193,0,0,6
217,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3532336580063696,2.7481155778894473,2.859759203151123,['CEBPB'],0.7176053142381652,0,0,1
218,Ketogenesis and Ketolysis WP4742,0.3532336580063696,2.7481155778894473,2.859759203151123,['SLC16A1'],0.7176053142381652,0,0,1
219,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3532336580063696,2.7481155778894473,2.859759203151123,['STAT5A'],0.7176053142381652,0,0,1
220,NAD Biosynthesis II (from tryptophan) WP2485,0.3532336580063696,2.7481155778894473,2.859759203151123,['HAAO'],0.7176053142381652,0,0,1
221,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.3532336580063696,2.7481155778894473,2.859759203151123,['RELA'],0.7176053142381652,0,0,1
222,Thiamine metabolic pathways WP4297,0.3532336580063696,2.7481155778894473,2.859759203151123,['SLC25A19'],0.7176053142381652,0,0,1
223,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.3598454896460968,1.6915336236090952,1.728883591141466,"['MKNK2', 'MAP2K6']",0.7180987426123436,0,0,2
224,Oxysterols derived from cholesterol WP4545,0.3598454896460968,1.6915336236090952,1.728883591141466,"['CH25H', 'ACOT11']",0.7180987426123436,0,0,2
225,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.3598454896460968,1.6915336236090952,1.728883591141466,"['RELA', 'VEGFA']",0.7180987426123436,0,0,2
226,Pre-implantation embryo WP3527,0.3598454896460968,1.6915336236090952,1.728883591141466,"['ZFP36', 'MXD1']",0.7180987426123436,0,0,2
227,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.3668317304954297,1.2223628691983122,1.2258490922081404,"['NOTCH1', 'WNT5B', 'WNT5A', 'PROX1', 'RBPJ', 'HIF1A', 'MAP2K6']",0.7288154645525938,0,0,7
228,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.37310543462696677,1.3330276281095954,1.3142242506106765,"['PPP1R14B', 'XBP1', 'HSPA5', 'PPP1R3B']",0.7348058996365153,0,0,4
229,Exercise-induced Circadian Regulation WP410,0.37310543462696677,1.3330276281095954,1.3142242506106765,"['CEBPB', 'BTG1', 'NR1D2', 'ERC2']",0.7348058996365153,0,0,4
230,Metapathway biotransformation Phase I and II WP702,0.38917688951085627,1.2497130394857667,1.1793808266249008,"['NDST3', 'FMO4', 'FMO5', 'GAL3ST4', 'HS3ST1']",0.7620822002906198,0,0,5
231,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3907139366123253,1.5705300988319857,1.4759521585571616,"['BCL6', 'DUSP6']",0.7620822002906198,0,0,2
232,Genotoxicity pathway WP4286,0.39261674538428576,1.2936725762183814,1.209482105616278,"['ITPKC', 'CDKN1A', 'CEBPD', 'PCDH8']",0.7620822002906198,0,0,4
233,Corticotropin-releasing hormone signaling pathway WP2355,0.4004693020483019,1.199724169635674,1.0978893799984786,"['HSP90AA1', 'PRKCQ', 'TCF4', 'JUNB', 'TBX19', 'RELA']",0.7620822002906198,0,0,6
234,Canonical NF-KB pathway WP4562,0.40723239527724914,2.1982412060301506,1.9748367236464242,['RELA'],0.7620822002906198,0,0,1
235,Cell Differentiation - Index WP2029,0.40723239527724914,2.1982412060301506,1.9748367236464242,['STAT3'],0.7620822002906198,0,0,1
236,Cells and molecules involved in local acute inflammatory response  WP4493,0.40723239527724914,2.1982412060301506,1.9748367236464242,['SELPLG'],0.7620822002906198,0,0,1
237,HIF1A and PPARG regulation of glycolysis WP2456,0.40723239527724914,2.1982412060301506,1.9748367236464242,['HIF1A'],0.7620822002906198,0,0,1
238,Major receptors targeted by epinephrine and norepinephrine WP4589,0.40723239527724914,2.1982412060301506,1.9748367236464242,['ADRB2'],0.7620822002906198,0,0,1
239,Nanomaterial-induced inflammasome activation WP3890,0.40723239527724914,2.1982412060301506,1.9748367236464242,['CASP1'],0.7620822002906198,0,0,1
240,Selective expression of chemokine receptors during T-cell polarization WP4494,0.40723239527724914,2.1982412060301506,1.9748367236464242,['IL4R'],0.7620822002906198,0,0,1
241,Supression of HMGB1 mediated inflammation by THBD WP4479,0.40723239527724914,2.1982412060301506,1.9748367236464242,['RELA'],0.7620822002906198,0,0,1
242,Glioblastoma signaling pathways WP2261,0.4310569257054005,1.1573624326302483,0.973937985680633,"['CDKN1A', 'SRC', 'PRKCQ', 'BRCA1', 'MAP2K6', 'FGFR1']",0.8033333615418827,0,0,6
243,Calcium Regulation in the Cardiac Cell WP536,0.4333375075406351,1.1119745622540353,0.9298758192847891,"['CHRM3', 'RYR2', 'CACNA1B', 'PRKCQ', 'CACNA1C', 'ADRB2', 'CALR', 'RGS6', 'RGS7']",0.8042601477400265,0,0,9
244,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.44035529482129887,1.2683588451850416,1.0402741733896137,"['DEPTOR', 'IGF1', 'PDK1']",0.8077815647713452,0,0,3
245,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.44035529482129887,1.2683588451850416,1.0402741733896137,"['IFNAR2', 'OAS1', 'IKBKE']",0.8077815647713452,0,0,3
246,PKC-gamma calcium signaling pathway in ataxia WP4760,0.4502883745203141,1.3738993710691825,1.096189064564817,"['GRM1', 'PDK1']",0.8077815647713452,0,0,2
247,Purinergic signaling WP4900,0.4502883745203141,1.3738993710691825,1.096189064564817,"['P2RY12', 'P2RY13']",0.8077815647713452,0,0,2
248,p53 transcriptional gene network WP4963,0.45042448044668426,1.1883712211581063,0.9478031158816662,"['CDKN1A', 'NOTCH1', 'DRAM1', 'TNFRSF10D']",0.8077815647713452,0,0,4
249,"Cerebral organic acidurias, including diseases WP4519",0.4567279357354613,1.8316582914572865,1.4354108762711613,['ADHFE1'],0.8077815647713452,0,0,1
250,Cytokines and Inflammatory Response WP530,0.4567279357354613,1.8316582914572865,1.4354108762711613,['IL15'],0.8077815647713452,0,0,1
251,Dual hijack model of Vif in HIV infection WP3300,0.4567279357354613,1.8316582914572865,1.4354108762711613,['RUNX1'],0.8077815647713452,0,0,1
252,Estrogen Receptor Pathway WP2881,0.4567279357354613,1.8316582914572865,1.4354108762711613,['STAT3'],0.8077815647713452,0,0,1
253,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4567279357354613,1.8316582914572865,1.4354108762711613,['PRKCQ'],0.8077815647713452,0,0,1
254,LDLRAD4 and what we know about it WP4904,0.4567279357354613,1.8316582914572865,1.4354108762711613,['PMEPA1'],0.8077815647713452,0,0,1
255,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4567279357354613,1.8316582914572865,1.4354108762711613,['BUB3'],0.8077815647713452,0,0,1
256,Pyrimidine metabolism WP4022,0.4734552562643424,1.121547103689961,0.8385783766832173,"['POLR1C', 'DPYD', 'ENPP1', 'POLR2K', 'TYMP']",0.8100981259776782,0,0,5
257,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4734552562643424,1.121547103689961,0.8385783766832173,"['GNA13', 'SRC', 'PDE4D', 'STAT3', 'MAP2K6']",0.8100981259776782,0,0,5
258,Nanoparticle triggered autophagic cell death WP2509,0.47881535324107216,1.2929337772844987,0.9521684608962311,"['VMP1', 'ATG14']",0.8100981259776782,0,0,2
259,CAMKK2  Pathway WP4874,0.4849070748217202,1.1774919035624325,0.8522662903579432,"['CHRM3', 'HMOX1', 'RELA']",0.8100981259776782,0,0,3
260,Phosphodiesterases in neuronal function WP4222,0.4849070748217202,1.1774919035624325,0.8522662903579432,"['PDE4D', 'PDE4B', 'PDE5A']",0.8100981259776782,0,0,3
261,IL-3 signaling pathway WP286,0.4879750313646002,1.1271704336017072,0.8087346862951899,"['STAT5A', 'SRC', 'IL3RA', 'STAT3']",0.8100981259776782,0,0,4
262,Pathogenic Escherichia coli infection WP2272,0.4879750313646002,1.1271704336017072,0.8087346862951899,"['HCLS1', 'LY96', 'CD14', 'TLR5']",0.8100981259776782,0,0,4
263,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4899091634922433,1.098989898989899,0.7841680715468985,"['HSPA5', 'HSPA6', 'CASP1', 'HSPA1B', 'HSPA1A']",0.8100981259776782,0,0,5
264,Circadian rhythm related genes WP3594,0.49444036881807546,1.0466509348339081,0.7371863174383517,"['CPT1A', 'PER3', 'KCND2', 'NFIL3', 'KCNH7', 'NAMPT', 'NR1D2', 'RORA', 'PROX1', 'TNFRSF11A']",0.8100981259776782,0,0,10
265,Biotin Metabolism (including IEMs) WP5031,0.5020953881357286,1.569813352476669,1.0815467093402877,['BTD'],0.8100981259776782,0,0,1
266,BMP Signaling Pathway in Eyelid Development WP3927,0.5020953881357286,1.569813352476669,1.0815467093402877,['NOTCH1'],0.8100981259776782,0,0,1
267,Fatty acid transporters WP5061,0.5020953881357286,1.569813352476669,1.0815467093402877,['ACSL1'],0.8100981259776782,0,0,1
268,Hypertrophy Model WP516,0.5020953881357286,1.569813352476669,1.0815467093402877,['VEGFA'],0.8100981259776782,0,0,1
269,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5020953881357286,1.569813352476669,1.0815467093402877,['NRG3'],0.8100981259776782,0,0,1
270,Nanoparticle triggered regulated necrosis WP2513,0.5020953881357286,1.569813352476669,1.0815467093402877,['FTL'],0.8100981259776782,0,0,1
271,NLR Proteins WP288,0.5020953881357286,1.569813352476669,1.0815467093402877,['RELA'],0.8100981259776782,0,0,1
272,RalA downstream regulated genes WP2290,0.5020953881357286,1.569813352476669,1.0815467093402877,['YBX3'],0.8100981259776782,0,0,1
273,TCA cycle in senescence WP5050,0.5020953881357286,1.569813352476669,1.0815467093402877,['PDK1'],0.8100981259776782,0,0,1
274,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5020953881357286,1.569813352476669,1.0815467093402877,['STAT3'],0.8100981259776782,0,0,1
275,Fragile X Syndrome  WP4549,0.5057713487055113,1.041023243387657,0.7096349304515999,"['CPT1A', 'GRM5', 'DEPTOR', 'SLC16A1', 'KCND2', 'SRC', 'GRM1', 'PDK1', 'HCN1']",0.8100981259776782,0,0,9
276,Endometrial cancer WP4155,0.5063551108020421,1.0988650693568727,0.7477964217609714,"['CDKN1A', 'CTNNA3', 'FGF2', 'FGFR1']",0.8100981259776782,0,0,4
277,miRNAs involvement in the immune response in sepsis WP4329,0.5064157396613683,1.2209643605870022,0.8307408874953917,"['IRF7', 'RELA']",0.8100981259776782,0,0,2
278,Nanoparticle-mediated activation of receptor signaling WP2643,0.5064157396613683,1.2209643605870022,0.8307408874953917,"['SRC', 'PXN']",0.8100981259776782,0,0,2
279,Oxidative Stress WP408,0.5064157396613683,1.2209643605870022,0.8307408874953917,"['HMOX1', 'JUNB']",0.8100981259776782,0,0,2
280,Type II interferon signaling (IFNG) WP619,0.5064157396613683,1.2209643605870022,0.8307408874953917,"['OAS1', 'PSMB9']",0.8100981259776782,0,0,2
281,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5065358570414751,1.136758446972987,0.7731778117614794,"['IFNAR2', 'CXCL12', 'IRF7']",0.8100981259776782,0,0,3
282,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5065358570414751,1.136758446972987,0.7731778117614794,"['SRC', 'PXN', 'STAT3']",0.8100981259776782,0,0,3
283,Head and Neck Squamous Cell Carcinoma WP4674,0.5222281867637192,1.056478243978244,0.6863417749774742,"['CDKN1A', 'NOTCH1', 'RELA', 'VEGFA', 'FGFR1']",0.831183293997579,0,0,5
284,Interferon type I signaling pathways WP585,0.5244347706603164,1.0719404545873958,0.6918670551417696,"['IFNAR2', 'STAT5A', 'STAT3', 'MAP2K6']",0.831183293997579,0,0,4
285,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5276821812850659,1.0987405541561712,0.7023821017387485,"['CH25H', 'ACSL1', 'ELOVL5']",0.831183293997579,0,0,3
286,IL-2 signaling pathway WP49,0.5276821812850659,1.0987405541561712,0.7023821017387485,"['STAT5A', 'STAT3', 'JAK3']",0.831183293997579,0,0,3
287,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5330454042654603,1.1565706719629263,0.7276549025770627,"['HSPB1', 'LITAF']",0.831183293997579,0,0,2
288,Melatonin metabolism and effects WP3298,0.5330454042654603,1.1565706719629263,0.7276549025770627,"['PER3', 'APOE']",0.831183293997579,0,0,2
289,TLR4 Signaling and Tolerance WP3851,0.5330454042654603,1.1565706719629263,0.7276549025770627,"['IRF7', 'IKBKE']",0.831183293997579,0,0,2
290,Wnt signaling pathway and pluripotency WP399,0.5380540440038578,1.0364255765199162,0.6423727067982463,"['WNT5B', 'LRRK2', 'WNT5A', 'PRKCQ', 'PPARD']",0.831183293997579,0,0,5
291,Cell Differentiation - Index expanded WP2023,0.5436786512844474,1.373429648241206,0.8369637991469178,['STAT3'],0.831183293997579,0,0,1
292,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5436786512844474,1.373429648241206,0.8369637991469178,['RYR2'],0.831183293997579,0,0,1
293,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5436786512844474,1.373429648241206,0.8369637991469178,['PRKCQ'],0.831183293997579,0,0,1
294,Overview of nanoparticle effects WP3287,0.5436786512844474,1.373429648241206,0.8369637991469178,['HMOX1'],0.831183293997579,0,0,1
295,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5436786512844474,1.373429648241206,0.8369637991469178,['TCF4'],0.831183293997579,0,0,1
296,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5483149293263746,1.0631754286178599,0.6388679290871937,"['WNT5B', 'WNT5A', 'ROR2']",0.8354393011020099,0,0,3
297,Glycerophospholipid Biosynthetic Pathway WP2533,0.558674010185554,1.0986163522012578,0.6396025114434307,"['PGS1', 'GK']",0.8455099952808216,0,0,2
298,Signal transduction through IL1R WP4496,0.558674010185554,1.0986163522012578,0.6396025114434307,"['RELA', 'MAP2K6']",0.8455099952808216,0,0,2
299,Chemokine signaling pathway WP3929,0.5674846889285193,0.9871690804745019,0.5592722613314148,"['FGR', 'CX3CR1', 'GNG10', 'CXCL12', 'PXN', 'STAT3', 'JAK3', 'RELA']",0.8458541600682462,0,0,8
300,IL-6 signaling pathway WP364,0.5684082539286364,1.0298331234256928,0.5817685512319065,"['STAT3', 'PRDM1', 'JUNB']",0.8458541600682462,0,0,3
301,PDGF Pathway WP2526,0.5684082539286364,1.0298331234256928,0.5817685512319065,"['SRC', 'STAT3', 'PDGFB']",0.8458541600682462,0,0,3
302,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5817930080520212,1.2206867671691792,0.6611734528986326,['MAP2K6'],0.8458541600682462,0,0,1
303,miRNAs involved in DNA damage response WP1545,0.5817930080520212,1.2206867671691792,0.6611734528986326,['CDKN1A'],0.8458541600682462,0,0,1
304,NAD+ metabolism WP3644,0.5817930080520212,1.2206867671691792,0.6611734528986326,['NAMPT'],0.8458541600682462,0,0,1
305,Nanomaterial induced apoptosis WP2507,0.5817930080520212,1.2206867671691792,0.6611734528986326,['CYCS'],0.8458541600682462,0,0,1
306,Neuroinflammation WP4919,0.5817930080520212,1.2206867671691792,0.6611734528986326,['RELA'],0.8458541600682462,0,0,1
307,Proteoglycan biosynthesis WP4784,0.5817930080520212,1.2206867671691792,0.6611734528986326,['CHSY1'],0.8458541600682462,0,0,1
308,Serotonin and anxiety WP3947,0.5817930080520212,1.2206867671691792,0.6611734528986326,['GRM1'],0.8458541600682462,0,0,1
309,Urea cycle and metabolism of amino groups WP497,0.5817930080520212,1.2206867671691792,0.6611734528986326,['ARG2'],0.8458541600682462,0,0,1
310,Vitamin A and carotenoid metabolism WP716,0.5817930080520212,1.2206867671691792,0.6611734528986326,['BCO2'],0.8458541600682462,0,0,1
311,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5832830239051543,1.0461814914645102,0.563978394566197,"['VMP1', 'PRDM1']",0.8458541600682462,0,0,2
312,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5879411902257731,0.9985115640027479,0.5303378021490087,"['DEPTOR', 'ATG14', 'FTL']",0.8498765281789219,0,0,3
313,MET in type 1 papillary renal cell carcinoma WP4205,0.5933073023586549,0.9762084909625893,0.5096226118150508,"['CDKN1A', 'SRC', 'STAT3', 'JAK3']",0.8521706795023992,0,0,4
314,Retinoblastoma gene in cancer WP2446,0.5933073023586549,0.9762084909625893,0.5096226118150508,"['CDKN1A', 'RPA3', 'HMGB2', 'SAP30']",0.8521706795023992,0,0,4
315,Parkinson's disease pathway WP2371,0.6068639603649741,0.9985134362492853,0.49870816585230476,"['LRRK2', 'CYCS']",0.8611272571923808,0,0,2
316,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6068639603649741,0.9985134362492853,0.49870816585230476,"['PRKCQ', 'RELA']",0.8611272571923808,0,0,2
317,Cancer immunotherapy by PD-1 blockade WP4585,0.6167275034881131,1.0984924623115577,0.5309321649766395,['STAT3'],0.8611272571923808,0,0,1
318,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6167275034881131,1.0984924623115577,0.5309321649766395,['PPARD'],0.8611272571923808,0,0,1
319,ERK Pathway in Huntington's Disease WP3853,0.6167275034881131,1.0984924623115577,0.5309321649766395,['GRM1'],0.8611272571923808,0,0,1
320,FOXA2 pathway WP5066,0.6167275034881131,1.0984924623115577,0.5309321649766395,['ABCC3'],0.8611272571923808,0,0,1
321,Globo Sphingolipid Metabolism WP1424,0.6167275034881131,1.0984924623115577,0.5309321649766395,['ST6GALNAC5'],0.8611272571923808,0,0,1
322,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6167275034881131,1.0984924623115577,0.5309321649766395,['UGCG'],0.8611272571923808,0,0,1
323,TP53 network WP1742,0.6167275034881131,1.0984924623115577,0.5309321649766395,['CDKN1A'],0.8611272571923808,0,0,1
324,Leptin signaling pathway WP2034,0.6273552926763681,0.9303843519945215,0.43378448791805896,"['PTPN1', 'SRC', 'STAT3', 'LEPR', 'RELA']",0.8705761138370525,0,0,5
325,T-cell receptor (TCR) signaling pathway WP69,0.6273552926763681,0.9303843519945215,0.43378448791805896,"['RIPK2', 'MAP3K8', 'PRKCQ', 'OPRM1', 'RELA']",0.8705761138370525,0,0,5
326,Folate Metabolism WP176,0.6294168392636049,0.9549904293136451,0.4421238400689578,"['PLAT', 'RELA']",0.8707576518646805,0,0,2
327,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6430332776785889,0.9149874055415617,0.4040207429166766,"['MAP3K8', 'PRKCQ', 'PDK1']",0.8816153790140835,0,0,3
328,Airway smooth muscle cell contraction WP4962,0.6487471259165247,0.9985153037916857,0.4320698284247907,['ADRB2'],0.8816153790140835,0,0,1
329,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6487471259165247,0.9985153037916857,0.4320698284247907,['WNT5A'],0.8816153790140835,0,0,1
330,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6487471259165247,0.9985153037916857,0.4320698284247907,['OAS1'],0.8816153790140835,0,0,1
331,ATM Signaling Pathway WP2516,0.6509488275203765,0.9150943396226415,0.3928721872150768,"['CDKN1A', 'BRCA1']",0.8816153790140835,0,0,2
332,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6509488275203765,0.9150943396226415,0.3928721872150768,"['PRKCQ', 'PDK1']",0.8816153790140835,0,0,2
333,PDGFR-beta pathway WP3972,0.6509488275203765,0.9150943396226415,0.3928721872150768,"['STAT5A', 'STAT3']",0.8816153790140835,0,0,2
334,Pancreatic adenocarcinoma pathway WP4263,0.654694290722253,0.8996729590991887,0.3810896653834876,"['CDKN1A', 'STAT3', 'DUSP6', 'RELA', 'VEGFA']",0.884033308729749,0,0,5
335,DNA damage response WP707,0.6601994598008957,0.8901558989720199,0.36960454856421704,"['CDKN1A', 'CYCS', 'BRCA1']",0.8861605844351307,0,0,3
336,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6601994598008957,0.8901558989720199,0.36960454856421704,"['WNT5B', 'WNT5A', 'ROR2']",0.8861605844351307,0,0,3
337,Autophagy WP4923,0.6714730492990557,0.8783899371069183,0.34984637292748333,"['DEPTOR', 'ATG14']",0.8864369794466198,0,0,2
338,miRNA regulation of DNA damage response WP1530,0.6767606271252312,0.866631313800875,0.3383654913528161,"['CDKN1A', 'CYCS', 'BRCA1']",0.8864369794466198,0,0,3
339,Selenium Micronutrient Network WP15,0.6767606271252312,0.866631313800875,0.3383654913528161,"['PLAT', 'ALOX15B', 'RELA']",0.8864369794466198,0,0,3
340,Synaptic Vesicle Pathway WP2267,0.6767606271252312,0.866631313800875,0.3383654913528161,"['UNC13C', 'CACNA1B', 'SYN3']",0.8864369794466198,0,0,3
341,Mitochondrial complex III assembly WP4921,0.6780948068937557,0.9152010050251256,0.35552645744518224,['UQCRQ'],0.8864369794466198,0,0,1
342,NAD+ biosynthetic pathways WP3645,0.6780948068937557,0.9152010050251256,0.35552645744518224,['NAMPT'],0.8864369794466198,0,0,1
343,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6780948068937557,0.9152010050251256,0.35552645744518224,['BCL2L14'],0.8864369794466198,0,0,1
344,Sleep regulation WP3591,0.6780948068937557,0.9152010050251256,0.35552645744518224,['PER3'],0.8864369794466198,0,0,1
345,Type II diabetes mellitus WP1584,0.6780948068937557,0.9152010050251256,0.35552645744518224,['GK'],0.8864369794466198,0,0,1
346,p38 MAPK Signaling Pathway WP400,0.6910075440790655,0.8445089501693275,0.3121343400675979,"['HSPB1', 'MAP2K6']",0.8991000902788856,0,0,2
347,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6927174663064875,0.8443131176128658,0.309975258003396,"['PIM1', 'PDK1', 'MAP2K6']",0.8991000902788856,0,0,3
348,Myometrial relaxation and contraction pathways WP289,0.6998847852927188,0.8626795619399801,0.307838186611751,"['RYR2', 'CALD1', 'PDE4D', 'PDE4B', 'PRKCQ', 'RGS6', 'RGS7']",0.8991000902788856,0,0,7
349,1q21.1 copy number variation syndrome WP4905,0.7049932547760376,0.8447042906841902,0.29528078187189233,['FMO5'],0.8991000902788856,0,0,1
350,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7049932547760376,0.8447042906841902,0.29528078187189233,['RAB27A'],0.8991000902788856,0,0,1
351,Monoamine Transport WP727,0.7049932547760376,0.8447042906841902,0.29528078187189233,['NECTIN2'],0.8991000902788856,0,0,1
352,Purine metabolism and related disorders WP4224,0.7049932547760376,0.8447042906841902,0.29528078187189233,['GRM5'],0.8991000902788856,0,0,1
353,Striated Muscle Contraction Pathway WP383,0.7049932547760376,0.8447042906841902,0.29528078187189233,['MYOM1'],0.8991000902788856,0,0,1
354,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7095743571497954,0.8131376659678546,0.2789793901801438,"['STAT3', 'GABRG3']",0.8991000902788856,0,0,2
355,Notch Signaling WP268,0.7095743571497954,0.8131376659678546,0.2789793901801438,"['NOTCH1', 'RBPJ']",0.8991000902788856,0,0,2
356,Wnt signaling WP428,0.7116995203128446,0.8280948868638321,0.28163463931917065,"['WNT5B', 'WNT5A', 'PRICKLE2', 'ROR2']",0.8991000902788856,0,0,4
357,ErbB signaling pathway WP673,0.717221908105755,0.8310376492194674,0.276211975991944,"['STAT5A', 'CDKN1A', 'NRG3', 'SRC', 'NRG1']",0.8991000902788856,0,0,5
358,G Protein Signaling Pathways WP35,0.717221908105755,0.8310376492194674,0.276211975991944,"['GNA13', 'GNG10', 'PDE4D', 'PDE4B', 'PRKCQ']",0.8991000902788856,0,0,5
359,Alzheimer's disease WP2059,0.7245621345813211,0.8126663864368783,0.261831161764624,"['VMP1', 'CYCS', 'CACNA1C', 'APOE']",0.8991000902788856,0,0,4
360,DNA damage response (only ATM dependent) WP710,0.7287087944067074,0.8185398763756973,0.2590523888084719,"['CDKN1A', 'WNT5B', 'BCL6', 'WNT5A', 'PDK1']",0.8991000902788856,0,0,5
361,Cell migration and invasion through p75NTR WP4561,0.7296466364569227,0.784278535534817,0.2472006115851183,['STAT3'],0.8991000902788856,0,0,1
362,DNA Mismatch Repair WP531,0.7296466364569227,0.784278535534817,0.2472006115851183,['RPA3'],0.8991000902788856,0,0,1
363,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7296466364569227,0.784278535534817,0.2472006115851183,['ANGPT2'],0.8991000902788856,0,0,1
364,Overview of interferons-mediated signaling pathway WP4558,0.7296466364569227,0.784278535534817,0.2472006115851183,['IFNAR2'],0.8991000902788856,0,0,1
365,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7296466364569227,0.784278535534817,0.2472006115851183,['SRC'],0.8991000902788856,0,0,1
366,Sphingolipid Metabolism (general overview) WP4725,0.7296466364569227,0.784278535534817,0.2472006115851183,['UGCG'],0.8991000902788856,0,0,1
367,Amyotrophic lateral sclerosis (ALS) WP2447,0.7439084962826386,0.7568857080893515,0.2239149793157577,"['CASP1', 'MAP2K6']",0.9071154967730614,0,0,2
368,Integrated Cancer Pathway WP1971,0.7439084962826386,0.7568857080893515,0.2239149793157577,"['CDKN1A', 'BRCA1']",0.9071154967730614,0,0,2
369,TGF-beta Receptor Signaling WP560,0.7439084962826386,0.7568857080893515,0.2239149793157577,"['STAT3', 'SPP1']",0.9071154967730614,0,0,2
370,Pathways Regulating Hippo Signaling WP4540,0.7489961456950096,0.7834624392001441,0.22643744347035474,"['CDH12', 'PRKCQ', 'CDH18', 'FGFR1']",0.9071154967730614,0,0,4
371,Small cell lung cancer WP4658,0.7505959395734296,0.7654208892273446,0.21958991641603004,"['CDKN1A', 'CYCS', 'RELA']",0.9071154967730614,0,0,3
372,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7522421192752217,0.7319095477386934,0.20837248159226798,['CDKN1A'],0.9071154967730614,0,0,1
373,Gastric Cancer Network 2 WP2363,0.7522421192752217,0.7319095477386934,0.20837248159226798,['RNF144B'],0.9071154967730614,0,0,1
374,Sphingolipid Metabolism (integrated pathway) WP4726,0.7522421192752217,0.7319095477386934,0.20837248159226798,['UGCG'],0.9071154967730614,0,0,1
375,Hippo-Merlin Signaling Dysregulation WP4541,0.7717353770959753,0.7562725572900814,0.19596047729731336,"['ITGAX', 'CDH12', 'CDH18', 'FGFR1']",0.9243165503665197,0,0,4
376,Integrin-mediated Cell Adhesion WP185,0.7717353770959753,0.7562725572900814,0.19596047729731336,"['SRC', 'PXN', 'ITGAX', 'MAP2K6']",0.9243165503665197,0,0,4
377,Tryptophan metabolism WP465,0.7729512847205982,0.6860866834170855,0.17669425224281038,['HAAO'],0.9243165503665197,0,0,1
378,Common Pathways Underlying Drug Addiction WP2636,0.7747043371142893,0.7078920673564617,0.18070631424621372,"['GRM5', 'GRM1']",0.9243165503665197,0,0,2
379,AMP-activated protein kinase (AMPK) signaling WP1403,0.7880035717880419,0.7152557222648122,0.17041157584103558,"['CDKN1A', 'CPT1A', 'LEPR']",0.9349766298264881,0,0,3
380,G1 to S cell cycle control WP45,0.7888536533167214,0.6856918238993711,0.16262858744004877,"['CDKN1A', 'RPA3']",0.9349766298264881,0,0,2
381,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7919314248197749,0.6456547443097842,0.1506186459163164,['SRC'],0.9349766298264881,0,0,1
382,MTHFR deficiency WP4288,0.7919314248197749,0.6456547443097842,0.1506186459163164,['CYCS'],0.9349766298264881,0,0,1
383,Pathways affected in adenoid cystic carcinoma WP3651,0.7993925242034772,0.6999571252478697,0.15672262936214354,"['CEBPA', 'NOTCH1', 'BRCA1']",0.9397363514585668,0,0,3
384,Nonalcoholic fatty liver disease WP4396,0.8018417376633442,0.775351346501116,0.17123171228462147,"['VMP1', 'CEBPA', 'XBP1', 'UQCRQ', 'LEPR', 'CYCS', 'COX7A1', 'RELA']",0.9397363514585668,0,0,8
385,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8022139585621911,0.6648370497427101,0.14651673945590232,"['STAT3', 'SPP1']",0.9397363514585668,0,0,2
386,Focal Adhesion WP306,0.8076917170770607,0.7591302168191503,0.16213110817122794,"['FGR', 'SRC', 'PXN', 'PDGFB', 'SPP1', 'IGF1', 'VEGFA']",0.9407380298968551,0,0,7
387,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8093267308203542,0.609715242881072,0.12898682871482825,['WNT5A'],0.9407380298968551,0,0,1
388,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8093267308203542,0.609715242881072,0.12898682871482825,['PDK1'],0.9407380298968551,0,0,1
389,IL-5 signaling pathway WP127,0.8148182169017729,0.6452090270070292,0.13213250979157815,"['STAT5A', 'STAT3']",0.943366382892864,0,0,2
390,Fatty Acid Biosynthesis WP357,0.8252693831511593,0.5775588468659085,0.11091753184864693,['ACSL1'],0.943366382892864,0,0,1
391,Physiological and pathological hypertrophy of the heart WP1528,0.8252693831511593,0.5775588468659085,0.11091753184864693,['STAT3'],0.943366382892864,0,0,1
392,Proximal tubule transport WP4917,0.8252693831511593,0.5775588468659085,0.11091753184864693,['SLC4A2'],0.943366382892864,0,0,1
393,Resistin as a regulator of inflammation WP4481,0.8252693831511593,0.5775588468659085,0.11091753184864693,['RELA'],0.943366382892864,0,0,1
394,B Cell Receptor Signaling Pathway WP23,0.825278061513548,0.7114161091433818,0.13661672505950662,"['BCL6', 'HCLS1', 'PIK3AP1', 'RELA', 'MAP2K6']",0.943366382892864,0,0,5
395,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8266993914501132,0.6267026055705301,0.11927036919672572,"['CDKN1A', 'NOTCH1']",0.943366382892864,0,0,2
396,Insulin Signaling WP481,0.8295114738293036,0.7484969614247181,0.13990780744665765,"['PTPN1', 'XBP1', 'ENPP1', 'FLOT2', 'MAP3K8', 'PRKCQ', 'SH2B2', 'MAP2K6']",0.943366382892864,0,0,8
397,TGF-beta Signaling Pathway WP366,0.8304134235220998,0.722107222739334,0.1341903417093686,"['CDKN1A', 'SRC', 'LIMK2', 'JUNB', 'PDK1', 'MAP2K6']",0.943366382892864,0,0,6
398,Regulation of Microtubule Cytoskeleton WP2038,0.8378902152057316,0.609224318658281,0.10775240570699914,"['SRC', 'STAT3']",0.9446038113123878,0,0,2
399,Alpha 6 Beta 4 signaling pathway WP244,0.8398805506347394,0.5486180904522613,0.09573144225080073,['SRC'],0.9446038113123878,0,0,1
400,DNA Replication WP466,0.8398805506347394,0.5486180904522613,0.09573144225080073,['RPA3'],0.9446038113123878,0,0,1
401,Sphingolipid pathway WP1422,0.8398805506347394,0.5486180904522613,0.09573144225080073,['UGCG'],0.9446038113123878,0,0,1
402,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.848423000141028,0.5926908040115587,0.09742411197363525,"['CACNA1C', 'GRM1']",0.9518377439393124,0,0,2
403,Wnt Signaling Pathway WP363,0.8583294797710439,0.577027474346243,0.08815089705449211,"['TCF4', 'ROR2']",0.9605622714063047,0,0,2
404,Thermogenesis WP4321,0.8619451631073795,0.6443142200133521,0.09572165695463122,"['CPT1A', 'ACSL1', 'MGLL', 'FGFR1']",0.9622209617857133,0,0,4
405,Copper homeostasis WP3286,0.8763868185949468,0.5480503144654087,0.07231398492975309,"['STEAP3', 'SCO2']",0.9715785221474995,0,0,2
406,GABA receptor Signaling WP4159,0.8767903736453044,0.4768953462967009,0.06270570140686782,['GABRG3'],0.9715785221474995,0,0,1
407,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8767903736453044,0.4768953462967009,0.06270570140686782,['PDK1'],0.9715785221474995,0,0,1
408,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8845972197948144,0.534621874520632,0.06555686137338602,"['PRKCQ', 'TLR2']",0.9778268287437778,0,0,2
409,miRNA regulation of prostate cancer signaling pathways WP3981,0.8965434914533811,0.438643216080402,0.04790355652916684,['CDKN1A'],0.9861978405987193,0,0,1
410,Neural Crest Cell Migration during Development WP4564,0.8965434914533811,0.438643216080402,0.04790355652916684,['STAT3'],0.9861978405987193,0,0,1
411,MAPK Cascade WP422,0.905200015876222,0.4217240046385775,0.04200343576462079,['MAP2K6'],0.9899591366010142,0,0,1
412,IL-1 signaling pathway WP195,0.9126337639132943,0.4868763102725367,0.0445105310708482,"['RELA', 'MAP2K6']",0.9899591366010142,0,0,2
413,Glycolysis and Gluconeogenesis WP534,0.9131330395255475,0.40605806811836964,0.036899995859911286,['SLC2A3'],0.9899591366010142,0,0,1
414,Mitochondrial CIV Assembly WP4922,0.9131330395255475,0.40605806811836964,0.036899995859911286,['SCO2'],0.9899591366010142,0,0,1
415,Prader-Willi and Angelman Syndrome WP3998,0.9131330395255475,0.40605806811836964,0.036899995859911286,['GABRG3'],0.9899591366010142,0,0,1
416,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9131330395255475,0.40605806811836964,0.036899995859911286,['RELA'],0.9899591366010142,0,0,1
417,Neural Crest Cell Migration in Cancer WP4565,0.9204029618782273,0.3915111270638909,0.03247338256310233,['STAT3'],0.9913262431281005,0,0,1
418,Ras signaling WP4223,0.9261681522496639,0.6016075343021839,0.04614297958183971,"['GNG10', 'PLA2G4C', 'RASA2', 'KSR2', 'RELA', 'FGFR1']",0.9913262431281005,0,0,6
419,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9270651458238325,0.37796742332351413,0.02862401720959521,['RELA'],0.9913262431281005,0,0,1
420,Netrin-UNC5B signaling pathway WP4747,0.9270651458238325,0.37796742332351413,0.02862401720959521,['SRC'],0.9913262431281005,0,0,1
421,Target Of Rapamycin (TOR) Signaling WP1471,0.9270651458238325,0.37796742332351413,0.02862401720959521,['PRR5'],0.9913262431281005,0,0,1
422,22q11.2 copy number variation syndrome WP4657,0.9293239774590989,0.45628930817610064,0.033445031252456056,"['EMC10', 'FGFR1']",0.9913262431281005,0,0,2
423,Mesodermal commitment pathway WP2857,0.9352265608794764,0.49736661323563086,0.03330688536215662,"['TRIM5', 'TCF4', 'FGFR1']",0.9913262431281005,0,0,3
424,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9387254570975309,0.437937106918239,0.02769173570214132,"['CDKN1A', 'CYCS']",0.9913262431281005,0,0,2
425,Glycogen Synthesis and Degradation WP500,0.9387650501946567,0.35350137785702707,0.022337767574028024,['PYGL'],0.9913262431281005,0,0,1
426,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9387650501946567,0.35350137785702707,0.022337767574028024,['SRC'],0.9913262431281005,0,0,1
427,Cell cycle WP179,0.9391856389095118,0.48988683785104703,0.03073653915607095,"['ANAPC13', 'CDKN1A', 'BUB3']",0.9913262431281005,0,0,3
428,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9424309327155485,0.5748885488056424,0.03408666165213672,"['STAT5A', 'SRC', 'STAT3', 'SPP1', 'RELA', 'SH2B2']",0.9913262431281005,0,0,6
429,DNA IR-damage and cellular response via ATR WP4016,0.9429688654145345,0.4293007769145394,0.025209405983738116,"['BCL6', 'BRCA1']",0.9913262431281005,0,0,2
430,Eukaryotic Transcription Initiation WP405,0.9485900181543242,0.33200091365920514,0.017522539539617032,['POLR2K'],0.9926081164445482,0,0,1
431,Nucleotide Excision Repair WP4753,0.9485900181543242,0.33200091365920514,0.017522539539617032,['RPA3'],0.9926081164445482,0,0,1
432,Integrated breast cancer pathway WP1984,0.9533222275584915,0.5302417377660096,0.02534678168316946,"['ITPKC', 'GRN', 'MAP3K7CL', 'BRCA1', 'VEGFA']",0.9941768364419212,0,0,5
433,Splicing factor NOVA regulated synaptic proteins WP4148,0.956840194978393,0.31295764536970566,0.013807342950017383,['EPB41L3'],0.9941768364419212,0,0,1
434,Endoderm differentiation WP2853,0.9585976673534053,0.44931161795659225,0.018998614115504797,"['NOTCH1', 'TRIM5', 'TCF4']",0.9941768364419212,0,0,3
435,ATM Signaling Network in Development and Disease  WP3878,0.9637677285707204,0.29597310878717914,0.010922875406319652,['HSPB1'],0.9941768364419212,0,0,1
436,16p11.2 proximal deletion syndrome WP4949,0.9657212909892319,0.37718499240945563,0.013156214437694333,"['SPN', 'MAP2K6']",0.9941768364419212,0,0,2
437,Rett syndrome causing genes WP4312,0.9668030889073875,0.28815128272943663,0.009728112701803996,['TCF4'],0.9941768364419212,0,0,1
438,EGF/EGFR signaling pathway WP437,0.9691619082505173,0.5194148455842514,0.01626993925821204,"['STAT5A', 'PLSCR1', 'SRC', 'LIMK2', 'STAT3', 'IQGAP1']",0.9941768364419212,0,0,6
439,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9721208634240404,0.45491803278688525,0.012862869776084114,"['PTPN1', 'FLOT2', 'MAP3K8', 'MAP2K6']",0.9941768364419212,0,0,4
440,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9721330041483088,0.27368090452261307,0.00773494716170399,['BRCA1'],0.9941768364419212,0,0,1
441,Energy Metabolism WP1541,0.9721330041483088,0.27368090452261307,0.00773494716170399,['PPARD'],0.9941768364419212,0,0,1
442,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9835192998867294,0.23781953244483287,0.003952089192001439,['TMEM70'],0.9974219917971462,0,0,1
443,7q11.23 copy number variation syndrome WP4932,0.9849017146775462,0.3166529942575882,0.004817376529088076,"['VPS9D1', 'NRG1']",0.9974219917971462,0,0,2
444,Melanoma WP4685,0.9883901691861562,0.2186934673366834,0.0025538478802385653,['CDKN1A'],0.9974219917971462,0,0,1
445,Ciliopathies WP4803,0.988432069667154,0.355738692366663,0.004139147521385256,"['NME9', 'LRRC6', 'DNAAF4']",0.9974219917971462,0,0,3
446,Amino Acid metabolism WP3925,0.9902561565831738,0.21023386161577115,0.0020585311980099693,['ARG2'],0.9974219917971462,0,0,1
447,Proteasome Degradation WP183,0.9931372075557566,0.19512742282842785,0.0013437351829857175,['PSMB9'],0.9974219917971462,0,0,1
448,Male infertility WP4673,0.9942407131998515,0.18835557095823946,0.0010879296187548653,['MSH5'],0.9974219917971462,0,0,1
449,DNA Repair Pathways Full Network WP4946,0.9952104131013655,0.25965858041329737,0.0012466451814892845,"['RPA3', 'BRCA1']",0.9974219917971462,0,0,2
450,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9952104131013655,0.25965858041329737,0.0012466451814892845,"['UQCRQ', 'COX7A1']",0.9974219917971462,0,0,2
451,Ciliary landscape WP4352,0.9986348850829477,0.3369486793399837,0.00046028791292530434,"['CTSA', 'DOCK5', 'CDH23', 'IQGAP1', 'IQGAP2']",0.9986348850829477,0,0,5
